NCT04480580View on ClinicalTrials.gov

Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

March 30, 2020

Primary Completion Date

April 30, 2020

Study Completion Date

June 30, 2020

Conditions

Covid19SurgerySARS (Severe Acute Respiratory Syndrome)

Interventions

DIAGNOSTIC_TEST

SARS-CoV-2 Ab

Patient test for specific antibodies for SARS-CoV-2

Trial Locations (1)

09100

AOU Cagliari, Cagliari

All Listed Sponsors

lead

University of Cagliari

OTHER

NCT04480580 - Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery | Biotech Hunter | Biotech Hunter